✦ LIBER ✦

An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents

✍ Scribed by Julien Péron,Valentine Polivka,Sylvie Chabaud,Marc Poupart…

Book ID: 126371256
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 343 KB
Volume: 14
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-14-504

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic significance of human papillo

Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials

✍ Argiris, A.; Li, S.; Ghebremichael, M.; Egloff, A. M.; Wang, L.; Forastiere, A. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 207 KB

Phase III Randomized, Placebo-Controlled

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

✍ Argiris, A.; Ghebremichael, M.; Gilbert, J.; Lee, J.-W.; Sachidanandam, K.; Kole 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 328 KB

5081 Triple combination of 3-weekly tras

5081 Triple combination of 3-weekly trastuzumab (T) plus oral vinorelbine (VNR) and capecitabine (CAP) as first-line treatment in HER2-positive metastatic breast cancer (MBC): an active and well-tolerated regimen that allows patient compliance

✍ R. Palumbo; A. Bernardo; M.R. Strada; G. Poggi; C. Teragni; A. Amatu; M. Frascar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB